Nanoparticle-Based Vaccines and Therapeutics for Multidrug-Resistant Pathogens
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 6
Special Issue Editors
Interests: antibiotic resistance; innate immunity; multidrug-resistant pathogens
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In this Special Issue, we highlight the impact that nanoparticle-based vaccines and therapeutics can play in the fight against multidrug-resistant pathogens. As the spread of antimicrobial resistance continues to reduce the available pool of effective therapeutics, the development of novel strategies is essential to prevent infection and overcome existing resistance reservoirs. The intersection of nanotechnology and medicine, creating nanotherapeutics, offers enormous promise in terms of solving the challenges faced when overcoming MDR pathogens. For example, nanovaccines and nanotherapeutics can be synthesized to optimize uptake by a desired immune cell population or tailored to enhance biodistribution. By harnessing the benefits conferred by nanotechnology into new vaccine and therapeutic applications, we unlock new mechanistic insights that can aid rational drug design and improve clinical options. This Special Issue discusses how the intersection of nanotechnology, vaccines, and therapeutics advances the frontier in terms of identifying and developing novel solutions to the multidrug resistance crisis.
As a guest editor, I invite you to submit research articles, review articles, and short communications related to nanoparticle-based vaccines and therapeutics in the context of multidrug-resistant infections.
Prof. Dr. Victor Nizet
Dr. Elisabet Bjånes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- nanotherapeutic
- nanovaccine
- nanomedicine
- pathogen
- multidrug resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
